Bone disorders in chronic liver diseases

Current Gastroenterology Reports

Volumn 13, Issue 1, 2011, Pages 40-48

  Luxon, Bruce A ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone disease; Bone mineral density; Chronic liver disease; Cirrhosis; Hepatic osteodystrophy; Osteomalacia; Osteoporosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; CALCIUM; COLECALCIFEROL; COLESTYRAMINE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; ESTROGEN; ETIDRONIC ACID; GLUCOCORTICOID; IBANDRONIC ACID; INTERLEUKIN 17; OSTEOCALCIN; PAMIDRONIC ACID; PARATHYROID HORMONE; PLACEBO; RALOXIFENE; RISEDRONIC ACID; SOMATOMEDIN C; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR; VITAMIN D; ZOLEDRONIC ACID;

ACUTE DISEASE; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; BONE BIOPSY; BONE DENSITY; BONE FRAGILITY; BONE MASS; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG SAFETY; DRUG TOLERABILITY; FRACTURE; HEMOCHROMATOSIS; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; INFLAMMATORY DISEASE; LIFESTYLE MODIFICATION; LIVER TOXICITY; LIVER TRANSPLANTATION; OSTEODYSTROPHY; OSTEOLYSIS; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; VERTEBRA FRACTURE; VIRUS HEPATITIS;

BONE DENSITY; BONE DISEASES, METABOLIC; CHRONIC DISEASE; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; OSTEOMALACIA; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PREVALENCE; RISK FACTORS;

EID: 79551544235     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-010-0166-4     Document Type: Article

References (56)

1. M Courbebaisse JC Souberbielle E Thervet 2010 Potential nonclassical effects of vitamin D in transplant recipients Transplantation 89 2 131 137 1:CAS:528:DC%2BC3cXpsVSlug%3D%3D 10.1097/TP.0b013e3181c6910f 20098273
2. BA Crawford ED Labio SI Strasser, et al. 2006 Vitamin D replacement for cirrhosis-related bone disease Nat Clin Pract Gastroenterol Hepatol 3 12 689 699 1:CAS:528:DC%2BD28XhtlClsrfF 10.1038/ncpgasthep0637 17130879 (Pubitemid 44824697)
3. WHO 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group World Health Organ Tech Rep Ser 843 1 129
4. Collier JD, Ninkovic M, Compston JE: Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 2002, 50 Suppl 1(1):i1-9.
5. WD Leslie CN Bernstein MS Leboff 2003 AGA technical review on osteoporosis in hepatic disorders Gastroenterology 125 3 941 966 10.1016/S0016-5085(03)01062-X 12949738 (Pubitemid 37070710)
6. D Marshall O Johnell H Wedel 1996 Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures BMJ 312 7041 1254 1259 1:STN:280:DyaK283isFejtw%3D%3D 8634613
7. AJ Stellon A Webb J Compston, et al. 1987 Low bone turnover state in primary biliary cirrhosis Hepatology 7 1 137 142 1:STN:280:DyaL2s7gslensg%3D%3D 10.1002/hep.1840070127 3804193 (Pubitemid 17019865)
8. Guanabens N, Pares A: Liver and bone. Arch Biochem Biophys 2010, ePub ahead of print.
9. CH Janes ER Dickson R Okazaki, et al. 1995 Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice J Clin Invest 95 6 2581 2586 1:CAS:528:DyaK2MXmtV2qs78%3D 10.1172/JCI117959 7769100
10. TH Diamond D Stiel M Lunzer, et al. 1989 Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease Gastroenterology 96 1 213 221 1:STN:280: DyaL1M%2FnvVyrtQ%3D%3D 2783312
11. A Cemborain I Castilla-Cortazar M Garcia, et al. 2000 Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis J Physiol Biochem 56 2 91 99 1:CAS:528:DC%2BD3cXntFKqu7o%3D 10.1007/BF03179904 11014614
12. IA Nakchbandi SW van der Merwe 2009 Current understanding of osteoporosis associated with liver disease Nat Rev Gastroenterol Hepatol 6 11 660 670 10.1038/nrgastro.2009.166 19881518
13. M Ninkovic SA Love B Tom, et al. 2001 High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation Calcif Tissue Int 69 6 321 326 1:CAS:528:DC%2BD38XpvFyksQ%3D%3D 10.1007/s00223-001-2028-4 11800228 (Pubitemid 34056794)
14. J Collier 2007 Bone disorders in chronic liver disease Hepatology 46 4 1271 1278 1:CAS:528:DC%2BD2sXht1aksrvK 10.1002/hep.21852 17886334 (Pubitemid 350144791)
15. P Angulo TM Therneau A Jorgensen, et al. 1998 Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression J Hepatol 29 5 729 735 1:STN:280:DyaK1M%2FkvFKmtA%3D%3D 10.1016/S0168-8278(98)80253-5 9833910 (Pubitemid 28505929)
16. MM Guichelaar J Schmoll M Malinchoc, et al. 2007 Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors Hepatology 46 4 1198 1207 10.1002/hep.21805 17654700 (Pubitemid 350144784)
17. N Guanabens A Pares I Ros, et al. 2005 Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis J Hepatol 42 4 573 577 1:CAS:528:DC%2BD2MXitFyru7c%3D 10.1016/j.jhep.2004.11.035 15763344 (Pubitemid 40342938)
18. M Solaymani-Dodaran TR Card GP Aithal, et al. 2006 Fracture risk in people with primary biliary cirrhosis: a population-based cohort study Gastroenterology 131 6 1752 1757 10.1053/j.gastro.2006.09.012 17087953 (Pubitemid 44958513)
19. K Masaki S Shiomi T Kuroki, et al. 1998 Longitudinal changes of bone mineral content with age in patients with cirrhosis of the liver J Gastroenterol 33 2 236 240 1:STN:280:DyaK1c3ms12qsA%3D%3D 10.1007/s005350050076 9605955 (Pubitemid 28143403)
20. I Schiefke A Fach M Wiedmann, et al. 2005 Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection World J Gastroenterol 11 12 1843 1847 1:CAS:528:DC%2BD2MXjvFSisbY%3D 15793878
21. P Guggenbuhl Y Deugnier JF Boisdet, et al. 2005 Bone mineral density in men with genetic hemochromatosis and HFE gene mutation Osteoporos Int 16 12 1809 1814 1:CAS:528:DC%2BD2MXhtlWkt7%2FF 10.1007/s00198-005-1934-0 15928800 (Pubitemid 41790893)
22. P Peris N Guanabens A Pares, et al. 1995 Vertebral fractures and osteopenia in chronic alcoholic patients Calcif Tissue Int 57 2 111 114 1:CAS:528:DyaK2MXnt1Ggur0%3D 10.1007/BF00298430 7584870
23. M Navasa A Monegal N Guanabens, et al. 1994 Bone fractures in liver transplant patients Br J Rheumatol 33 1 52 55 1:STN:280:DyaK2c3hsFSitw%3D%3D 10.1093/rheumatology/33.1.52 8162459 (Pubitemid 24042037)
24. RP Sokhi A Anantharaju R Kondaveeti, et al. 2004 Bone mineral density among cirrhotic patients awaiting liver transplantation Liver Transpl 10 5 648 653 10.1002/lt.20104 15108256 (Pubitemid 38628225)
25. R Eastell ER Dickson SF Hodgson, et al. 1991 Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis Hepatology 14 2 296 300 1:STN:280:DyaK3MzhslGjtg%3D%3D 10.1002/hep.1840140215 1860685
26. F Atamaz S Hepguler Z Karasu, et al. 2006 The prevention of bone fractures after liver transplantation: experience with alendronate treatment Transplant Proc 38 5 1448 1452 1:STN:280:DC%2BD28zotlaqtA%3D%3D 10.1016/j.transproceed.2006.02.074 16797329
27. A Pares N Guanabens A Pares, et al. 2006 Treatment of bone disorders in liver disease Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment. J Hepatol 45 3 445 453 1:CAS:528:DC%2BD28Xns1SltLc%3D
28. A Pares N Guanabens 2008 Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment Clin Liver Dis 12 2 407 424 10.1016/j.cld.2008.02.005 18456188 (Pubitemid 351635892)
29. JS Crippin RA Jorgensen ER Dickson, et al. 1994 Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment Am J Gastroenterol 89 1 47 50 1:STN:280:DyaK2c%2FpvFemtQ%3D%3D 8273797
30. S Shiomi K Masaki D Habu, et al. 1999 Calcitriol for bone loss in patients with primary biliary cirrhosis J Gastroenterol 34 2 241 245 1:CAS:528:DyaK1MXisFaqt7k%3D 10.1007/s005350050250 10213125 (Pubitemid 29192565)
31. N Guanabens A Pares I Ros, et al. 2003 Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis Am J Gastroenterol 98 10 2268 2274 1:CAS:528:DC%2BD3sXot12it7g%3D 14572578
32. CO Zein RA Jorgensen B Clarke, et al. 2005 Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial Hepatology 42 4 762 771 1:CAS:528:DC%2BD2MXhtFGlsbjJ 10.1002/hep.20866 16175618 (Pubitemid 41401113)
33. N Guanabens A Enjuanes L Alvarez, et al. 2009 High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue J Bone Miner Metab 27 3 347 354 1:CAS:528:DC%2BD1MXksF2hs7g%3D 10.1007/s00774-009-0042-1 19229472
34. A Monegal N Guanabens MJ Suarez, et al. 2009 Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial Transpl Int 22 2 198 206 1:CAS:528:DC%2BD1MXislOgs7Y%3D 10.1111/j.1432-2277.2008.00763.x 18796000
35. BA Crawford C Kam J Pavlovic, et al. 2006 Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial Ann Intern Med 144 4 239 248 1:CAS:528:DC%2BD28Xit1Kjsrk%3D 16490909
36. R Olsson LA Mattsson K Obrant, et al. 1999 Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis Liver 19 3 188 192 1:CAS:528:DyaK1MXktFSjt7g%3D 10.1111/j.1478-3231.1999.tb00034.x 10395037 (Pubitemid 29261584)
37. S Hulley C Furberg E Barrett-Connor, et al. 2002 Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) Jama 288 1 58 66 1:CAS:528:DC%2BD38XkvF2rtrc%3D 10.1001/jama.288.1.58 12090863 (Pubitemid 34705519)
38. C Levy DM Harnois P Angulo, et al. 2005 Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study Liver Int 25 1 117 121 1:CAS:528:DC%2BD2MXisFCqt7c%3D 10.1111/j.1478-3231.2005.01026.x 15698408 (Pubitemid 40298253)
39. A Floreani F Zappala W Fries, et al. 1997 A 3-year pilot study with 1, 25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis J Clin Gastroenterol 24 4 239 244 1:STN:280: DyaK2szps1Krtw%3D%3D 10.1097/00004836-199706000-00012 9252849 (Pubitemid 27310595)
40. M Camisasca A Crosignani PM Battezzati, et al. 1994 Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis Hepatology 20 3 633 637 1:STN:280:DyaK2czlslGntA%3D%3D 10.1016/0270-9139(94)90098-1 8076921 (Pubitemid 24271271)
41. S Feitelberg S Epstein F Ismail, et al. 1987 Deranged bone mineral metabolism in chronic alcoholism Metabolism 36 4 322 326 1:STN:280: DyaL2s7nt1aluw%3D%3D 10.1016/0026-0495(87)90201-0 3494181 (Pubitemid 17057912)
42. K Laitinen M Karkkainen M Lalla, et al. 1993 Is alcohol an osteoporosis-inducing agent for young and middle-aged women? Metabolism 42 7 875 881 1:STN:280:DyaK3szkslKgsQ%3D%3D 10.1016/0026-0495(93)90063-T 8345798 (Pubitemid 23207117)
43. HC Mitchison AJ Malcolm MF Bassendine, et al. 1988 Metabolic bone disease in primary biliary cirrhosis at presentation Gastroenterology 94 2 463 470 1:STN:280:DyaL1c%2FosVartg%3D%3D 3335317
44. FN Van Berkum R Beukers JC Birkenhager, et al. 1990 Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids Gastroenterology 99 4 1134 1139 2394334
45. N Guanabens A Pares L Marinoso, et al. 1990 Factors influencing the development of metabolic bone disease in primary biliary cirrhosis Am J Gastroenterol 85 10 1356 1362 1:STN:280:DyaK3M%2Fit1KisA%3D%3D 2220729
46. KD Lindor CH Janes JS Crippin, et al. 1995 Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 21 2 389 392 1:STN:280:DyaK2M7ks1Snsw%3D%3D 7843710
47. MM Guichelaar R Kendall M Malinchoc, et al. 2006 Bone mineral density before and after OLT: long-term follow-up and predictive factors Liver Transpl 12 9 1390 1402 10.1002/lt.20874 16933236 (Pubitemid 44405129)
48. CC Chen SS Wang FS Jeng, et al. 1996 Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol 11 5 417 421 1:STN:280:DyaK28zjvVKgtQ%3D%3D 10.1111/j.1440-1746.1996. tb00284.x 8743912
49. FJ Gallego-Rojo JL Gonzalez-Calvin M Munoz-Torres, et al. 1998 Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis Hepatology 28 3 695 699 1:STN:280:DyaK1cvgtVartQ%3D%3D 10.1002/hep.510280315 9731561
50. HL Bonkovsky M Hawkins K Steinberg, et al. 1990 Prevalence and prediction of osteopenia in chronic liver disease Hepatology 12 2 273 280 1:STN:280:DyaK3czmtFaitA%3D%3D 10.1002/hep.1840120214 2391068 (Pubitemid 20285790)
51. A Monegal M Navasa N Guanabens, et al. 1997 Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation Calcif Tissue Int 60 2 148 154 1:CAS:528:DyaK2sXhtVagsrk%3D 10.1007/s002239900205 9056162 (Pubitemid 27058703)
52. L Sinigaglia S Fargion AL Fracanzani, et al. 1997 Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload J Rheumatol 24 9 1809 1813 1:STN:280:DyaK2svjvVeiuw%3D%3D 9292808
53. A Pares N Guanabens I Ros 1999 Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis Hepatology 30 472A 10.1016/S0168-8278(99)80107-X (Pubitemid 29113237)
54. O Epstein Y Kato R Dick, et al. 1982 Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis Am J Clin Nutr 36 3 426 430 1:STN:280: DyaL383otFansQ%3D%3D 6287835
55. N Guanabens A Pares A Monegal, et al. 1997 Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years Gastroenterology 113 1 219 224 1:CAS:528:DyaK2sXks1Ojtrg%3D 10.1016/S0016-5085(97)70098-2 9207281 (Pubitemid 27281777)
56. FH Wolfhagen HR van Buuren JW den Ouden, et al. 1997 Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study J Hepatol 26 2 325 330 1:CAS:528:DyaK2sXhvVSnsbg%3D 10.1016/S0168-8278(97)80048-7 9059953 (Pubitemid 27077431)